D J Pohlod

473 total citations
19 papers, 370 citations indexed

About

D J Pohlod is a scholar working on Infectious Diseases, Pharmacology and Molecular Biology. According to data from OpenAlex, D J Pohlod has authored 19 papers receiving a total of 370 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 8 papers in Pharmacology and 5 papers in Molecular Biology. Recurrent topics in D J Pohlod's work include Antibiotics Pharmacokinetics and Efficacy (8 papers), Antimicrobial Resistance in Staphylococcus (6 papers) and Antifungal resistance and susceptibility (4 papers). D J Pohlod is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (8 papers), Antimicrobial Resistance in Staphylococcus (6 papers) and Antifungal resistance and susceptibility (4 papers). D J Pohlod collaborates with scholars based in United States and Germany. D J Pohlod's co-authors include Louis D. Saravolatz, Edward Quinn, Daniel Havlichek, T. Madhavan, Evelyn J. Fisher, Felicia Cox, Norman Markowitz, Nathan W. Levin, Antone A. Medeiros and V. Jiménez-Lucho and has published in prestigious journals such as Journal of Clinical Microbiology, The Journal of Infectious Diseases and Antimicrobial Agents and Chemotherapy.

In The Last Decade

D J Pohlod

19 papers receiving 320 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D J Pohlod United States 11 146 130 115 96 95 19 370
Robert M. Lumish United States 8 116 0.8× 63 0.5× 117 1.0× 137 1.4× 79 0.8× 10 372
C Restieri Canada 10 108 0.7× 142 1.1× 55 0.5× 187 1.9× 67 0.7× 11 402
Jacques Dubois Canada 13 119 0.8× 91 0.7× 127 1.1× 225 2.3× 48 0.5× 27 447
N. J. Pearson United Kingdom 11 42 0.3× 51 0.4× 135 1.2× 177 1.8× 95 1.0× 16 428
Valeria Crivaro Italy 11 63 0.4× 62 0.5× 314 2.7× 118 1.2× 173 1.8× 13 498
Yuarn‐Jang Lee Taiwan 13 104 0.7× 65 0.5× 231 2.0× 198 2.1× 58 0.6× 35 507
Matthew F. Wack United States 10 204 1.4× 72 0.6× 78 0.7× 197 2.1× 18 0.2× 15 443
Yaara Leibovici‐Weissman Israel 12 51 0.3× 73 0.6× 88 0.8× 120 1.3× 60 0.6× 24 431
Kenneth Kaplan United States 11 135 0.9× 113 0.9× 45 0.4× 88 0.9× 7 0.1× 15 375
C. Petermüller Germany 8 148 1.0× 94 0.7× 131 1.1× 96 1.0× 42 0.4× 11 364

Countries citing papers authored by D J Pohlod

Since Specialization
Citations

This map shows the geographic impact of D J Pohlod's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D J Pohlod with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D J Pohlod more than expected).

Fields of papers citing papers by D J Pohlod

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D J Pohlod. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D J Pohlod. The network helps show where D J Pohlod may publish in the future.

Co-authorship network of co-authors of D J Pohlod

This figure shows the co-authorship network connecting the top 25 collaborators of D J Pohlod. A scholar is included among the top collaborators of D J Pohlod based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D J Pohlod. D J Pohlod is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Pohlod, D J & Louis D. Saravolatz. (1991). Comparison of five commercial western blot kits for detection of human immunodeficiency virus 1. European Journal of Clinical Microbiology & Infectious Diseases. 10(5). 453–457. 2 indexed citations
2.
Frinak, Stanley, et al.. (1991). Filtration of Dialysate Using An On-Line Dialysate Filter. The International Journal of Artificial Organs. 14(11). 691–697. 14 indexed citations
3.
Snyder, Mark B., et al.. (1990). Reduction in Legionella pneumophila through Heat Flushing Followed by Continuous Supplemental Chlorination of Hospital Hot Water. The Journal of Infectious Diseases. 162(1). 127–132. 43 indexed citations
4.
Pohlod, D J, et al.. (1987). In vitro susceptibility of gram-positive cocci to paldimycin. Antimicrobial Agents and Chemotherapy. 31(1). 104–107. 4 indexed citations
5.
Havlichek, Daniel, Louis D. Saravolatz, & D J Pohlod. (1987). Effect of quinolones and other antimicrobial agents on cell-associated Legionella pneumophila. Antimicrobial Agents and Chemotherapy. 31(10). 1529–1534. 49 indexed citations
6.
Saravolatz, Louis D., et al.. (1986). Lack of bacterial aerosols associated with heat and moisture exchangers.. PubMed. 134(2). 214–6. 8 indexed citations
7.
Cárdenas, César, et al.. (1986). Single-dose cephalexin therapy for acute bacterial urinary tract infections and acute urethral syndrome with bladder bacteriuria. Antimicrobial Agents and Chemotherapy. 29(3). 383–385. 18 indexed citations
8.
Jiménez-Lucho, V., Louis D. Saravolatz, Antone A. Medeiros, & D J Pohlod. (1986). Failure of Therapy in Pseudomonas Endocarditis: Selection of Resistant Mutants. The Journal of Infectious Diseases. 154(1). 64–68. 26 indexed citations
9.
10.
Pohlod, D J & Louis D. Saravolatz. (1984). In vitro susceptibilities of 393 recent clinical isolates to WIN 49375, cefotaxime, tobramycin, and piperacillin. Antimicrobial Agents and Chemotherapy. 25(3). 377–379. 21 indexed citations
11.
Pohlod, D J, et al.. (1984). Comparison of fluorescence polarization immunoassay and bioassay of vancomycin. Journal of Clinical Microbiology. 20(2). 159–161. 9 indexed citations
12.
Markowitz, Norman, D J Pohlod, Louis D. Saravolatz, & Edward Quinn. (1983). In vitro susceptibility patterns of methicillin-resistant and-susceptible Staphylococcus auerues strains in a population of parenteral drug abusers from 1972 to 1981. Antimicrobial Agents and Chemotherapy. 23(3). 450–457. 39 indexed citations
13.
Saravolatz, Louis D., et al.. (1981). Failure of probenecid to alter the pharmacokinetics of ceforanide. Antimicrobial Agents and Chemotherapy. 20(4). 530–532. 7 indexed citations
14.
Pohlod, D J, et al.. (1980). Effect of clavulanic acid on minimal inhibitory concentrations of 16 antimicrobial agents tested against Legionella pneumophila. Antimicrobial Agents and Chemotherapy. 18(2). 353–354. 10 indexed citations
15.
Saravolatz, Louis D., D J Pohlod, & Edward Quinn. (1979). In Vitro Susceptibility of Legionella pneumophila, Serogroups I-IV. The Journal of Infectious Diseases. 140(2). 251–251. 14 indexed citations
16.
Pohlod, D J, et al.. (1978). In Vitro and Clinical Studies of Cefaclor, A New Cephalosporin. 26(4). 12–17. 1 indexed citations
17.
Madhavan, T., Nathan W. Levin, D J Pohlod, et al.. (1976). Effect of Renal Failure and Dialysis on the Serum Concentration of the Aminoglycoside Amikacin. Antimicrobial Agents and Chemotherapy. 10(3). 464–466. 22 indexed citations
18.
Madhavan, T., Nathan W. Levin, Evelyn J. Fisher, et al.. (1975). Effects of Renal Failure and Dialysis on Cefazolin Pharmacokinetics. Antimicrobial Agents and Chemotherapy. 8(1). 63–66. 20 indexed citations
19.
Quinn, Edward, et al.. (1973). Clinical Experiences with Cefazolin and Other Cephalosporins in Bacterial Endocarditis. The Journal of Infectious Diseases. 128(Supplement 2). S386–S391. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026